Studies have shown that upregulation of the canonical interferon-gamma signaling pathway is associated with glioblastoma progression, and its expression in the tumor microenvironment significantly impacts overall survival in pediatric diffuse midline glioma (DMG) patients (47, 70–73). This evidence concerns the gene IFNG and neoplasm.